Follow
Dr Trudi Collet PhD
Dr Trudi Collet PhD
Leader - Innovative Medicines Group (IMG)
Verified email at qut.edu.au - Homepage
Title
Cited by
Cited by
Year
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases
M Mehta, D Tewari, G Gupta, R Awasthi, H Singh, P Pandey, ...
Chemico-biological interactions 308, 206-215, 2019
4552019
The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress
K Dua, R Wadhwa, G Singhvi, V Rapalli, SD Shukla, MD Shastri, G Gupta, ...
Drug development research 80 (6), 714-730, 2019
2352019
Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems
K Dua, V Malyla, G Singhvi, R Wadhwa, RV Krishna, SD Shukla, ...
Chemico-biological interactions 299, 168-178, 2019
842019
Leptospirosis from water sources
SJ Wynwood, GC Graham, SL Weier, TA Collet, DB McKay, SB Craig
Pathogens and Global Health 108 (7), 334-338, 2014
732014
Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases
M Mehta, N Sharma, M Vyas, N Khurana, PK Maurya, H Singh, ...
Chemico-biological interactions 304, 10-19, 2019
722019
Molecular modulators of celastrol as the keystones for its diverse pharmacological activities
SW Ng, Y Chan, DK Chellappan, T Madheswaran, F Zeeshan, YL Chan, ...
Biomedicine & Pharmacotherapy 109, 1785-1792, 2019
662019
Recent update on anti-dengue drug discovery
SN Dighe, K Dua, DK Chellappan, PL Katavic, TA Collet
European journal of medicinal chemistry 176, 431-455, 2019
362019
Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary disease
R Wadhwa, T Aggarwal, V Malyla, N Kumar, G Gupta, DK Chellappan, ...
Journal of cellular physiology 234 (10), 16703-16723, 2019
332019
Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases
DK Chellappan, QLS Ning, SKS Min, SY Bin, PJ Chern, TP Shi, SWE Mei, ...
Chemico-biological interactions 310, 108732, 2019
282019
Recent advances in DNA gyrase-targeted antimicrobial agents
SN Dighe, TA Collet
European Journal of Medicinal Chemistry 199, 112326, 2020
262020
Emerging complexity and the need for advanced drug delivery in targeting Candida species
R Wadhwa, P Pandey, G Gupta, T Aggarwal, N Kumar, M Mehta, S Satija, ...
Current topics in medicinal chemistry 19 (28), 2593-2609, 2019
242019
Nanoparticle-based drug delivery for chronic obstructive pulmonary disorder and asthma: Progress and challenges
R Wadhwa, T Aggarwal, N Thapliyal, DK Chellappan, G Gupta, M Gulati, ...
Nanotechnology in modern animal biotechnology, 59-73, 2019
222019
The emergence of Leptospira borgpetersenii serovar Arborea as the dominant infecting serovar following the summer of natural disasters in Queensland, Australia 2011
S Wynwood, S Craig, G Graham, B Blair, MA Burns, S Weier, T Collet, ...
Tropical biomedicine 31 (2), 281-285, 2014
222014
Obesity and diabetes: pathophysiology of obesity-induced hyperglycemia and insulin resistance
G Gupta, R Wadhwa, P Pandey, SK Singh, M Gulati, S Sajita, M Mehta, ...
Pathophysiology of obesity-induced health complications, 81-97, 2020
192020
Applications of nanocarriers as drug delivery vehicles for active phytoconstituents
PQ Ng, LSC Ling, J Chellian, T Madheswaran, J Panneerselvam, ...
Current pharmaceutical design 26 (36), 4580-4590, 2020
182020
MicroRNAs as biomarker for breast cancer
T Aggarwal, R Wadhwa, R Gupta, KR Paudel, T Collet, DK Chellappan, ...
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2020
172020
Current status on immunological therapies for type 1 diabetes mellitus
GLL Xin, YP Khee, TY Ying, J Chellian, G Gupta, AP Kunnath, S Nammi, ...
Current diabetes reports 19 (5), 1-10, 2019
162019
Molecular and immunological mechanisms underlying the various pharmacological properties of the potent bioflavonoid, rutin
DOC Yong, SR Saker, DK Chellappan, T Madheswaran, ...
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2020
132020
Neutrophil counts in leptospirosis patients infected with different serovars
SB Craig, TA Collet, SJ Wynwood, LD Smythe, SL Weier, DB McKay
Trop Biomed 30 (4), 579-83, 2013
112013
Molecular signaling of G‐protein‐coupled receptor in chronic heart failure and associated complications
M Altamish, VP Samuel, R Dahiya, Y Singh, PK Deb, HA Bakshi, ...
Drug development research 81 (1), 23-31, 2020
102020
The system can't perform the operation now. Try again later.
Articles 1–20